https://www.thenation.com/article/society/covid-pandemic-panic-calm-advice/
“….Despite the end of the Public Health Emergency in May, Covid-19 remains a pandemic, by definition…”
“…History is replete with examples of pandemics that blazed for decades, sometimes smoldering for years
before flaring up again into catastrophe…“
“…This claim—that more disease risk and contagion means the end of a disease event—runs contrary to
the science. Many have claimed that widespread SARS-CoV-2 infections will lead to increasingly mild
disease that poses fewer concerns for an increasingly vaccinated (or previously infected) population. In
fact, more disease spread means faster evolution for SARS-CoV-2, and greater risks for public health. As we
(A.C. and collaborators) and others have pointed out, rapid evolution creates the risk of novel variants with
unpredictable severity. It also threatens the means that we have to prevent and treat Covid-19:
monoclonal antibody treatments no longer work, Paxlovid is showing signs of viral resistance, and booster
strategy is complicated by viral evolution of resistance to vaccines.…”
“…and others have pointed out, rapid evolution creates the risk of novel variants with unpredictable
severity…”
Geert: I firmly claim that 'widespread SARS-CoV-2 infections will lead to increasingly mild disease that
poses fewer concerns for a previously infected but unvaccinated population' !
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.
Email: info@voiceforscienceandsolidarity.org
.svg){kind=small}
